Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Targeting the B7 Family of Co-Stimulatory Molecules : Successes and Challenges.
Leukocyte counts in cerebrospinal fluid and blood following firategrast treatment in subjects with relapsing forms of multiple sclerosis.
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod.
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica.
Physiological Role of K(+) Channels in the Regulation of T Cell Function.
Axon damage in central nervous system and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of dysfunction and tissue damage.
Functional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study.
Myeloid cell distribution and activity in multiple sclerosis.
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
The effect of wheelchair use on the quality of life of persons with multiple sclerosis.
IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Perceived Cognitive Difficulties and Cognitive Test Performance as Predictors of Employment Outcomes in People with Multiple Sclerosis.
Two functional promoter polymorphisms of neuregulin 1 gene are associated with progressive forms of multiple sclerosis.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
Female sex hormones and cytokine secretion in women with multiple sclerosis.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
17β-estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Gait variability in people with neurological disorders: A systematic review and meta-analysis.
Early and Extensive Spinal White Matter Involvement in Neuromyelitis Optica.
Pages
« first
‹ previous
…
590
591
592
593
594
595
596
597
598
…
next ›
last »